GoldenGolden
Advanced Search
Advent Life Sciences

Advent Life Sciences

A venture capital and private equity firm investing in life science technology companies.

Advent Life Sciences is a venture capital and private equity firm investing in life science technology companies that is headquartered in London, England and was founded in 2010. The firm typically invests in life science companies in the United Kingdom, Europe, and the United States. Sectors of the life science industry that Advent Life Sciences invests in are new drug discovery, enabling technologies, medical technologies, and medical diagnostics.

Notable investments made by Advent Life Sciences include: Algeta, Avila, Biocartis, CardiacAssist, CardiAQ Valve Technologies, CardioKine, Callnovo, CN Creative, Conatus Pharmaceuticals, EUSA Pharma, KuDos Pharmaceuticals, Micromet, PowderMed, RespiVert, Santarus, Speciality European Pharma, Thiakis, and UniQure.

Investment funds
Fund II

On October 28, 2014 Advent Life Sciences announced raising $235 million for their second venture capital fund for backing early and mid-stage life science companies. Raj Parek, a general partner at Advent Life Sciences, made the following statement regarding the firms second fund:

We thank our returning and new LPs for the strength of their support, which allowed us to raise the commitments for this Fund in a matter of weeks. The interest from LPs and demand for the Fund, particularly in current markets, is in large part a recognition of the scientific and medical entrepreneurs, CEOs and Management teams whose commitment, vision and energy is enabling our portfolio companies to bring important medical innovations to patients. It is a privilege to work with them.

Timeline

February 18, 2021
Advent Life Sciences announces close of two new funds.

Advent Life Sciences, a leading transatlantic venture investor focused on building innovative life science companies in the UK, Europe and the US, announced today that it has closed two new funds with commitments totalling $215 million.

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
Advent Life Sciences
February 18, 2021
www.prnewswire.com:443
/PRNewswire/ -- Advent Life Sciences, a leading transatlantic venture investor focused on building innovative life science companies in the UK, Europe and the...

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.